We have investigated the expression of P2X 5 , P2X 7 , P2Y 1 , and P2Y 2 receptor subtypes in 8-to 11-wk-old human fetal epidermis in relation to markers of proliferation (proliferating cell nuclear antigen (PCNA) and , keratinocyte di¡erentiation (cytokeratin K10 and involucrin), and markers of apoptosis (TdTmediated dUTP nick end labeling (TUNEL) and anticaspase-3). Immunohistochemistry showed that each of the four receptors was expressed in spatially distinct zones of the developing epidermis: P2Y 1 receptors were found in the basal layer, P2X 5 receptors were predominantly in the basal and intermediate layers, and both P2Y 2 and P2X 7 receptors were in the periderm. Colocalization experiments suggested di¡erent functional roles for these receptors. P2Y 1 receptors were found in fetal keratinocytes positive for PCNA and Ki-67, suggesting a role in proliferation. P2X 5 receptors double labeled with di¡erentiated fetal keratinocytes that were positive for cytokeratin K10, suggesting a role in di¡er-entiation. P2X 7 receptors colocalized with anti-caspase-3 antibody and were also expressed in periderm cells positive for TUNEL, suggesting a role in periderm cell apoptosis. P2Y 2 receptors were found only in periderm cells and may have a role in chloride and £uid secretion into the amniotic £uid. There is increasing evidence that purinergic signaling can have long-term, trophic e¡ects in embryonic development, cell proliferation, di¡erentiation, and death (Abbracchio and Burnstock, 1998; Burnstock, 2001) .
We have investigated the expression of P2X 5 , P2X 7 , P2Y 1 , and P2Y 2 receptor subtypes in 8-to 11-wk-old human fetal epidermis in relation to markers of proliferation (proliferating cell nuclear antigen (PCNA) and , keratinocyte di¡erentiation (cytokeratin K10 and involucrin), and markers of apoptosis (TdTmediated dUTP nick end labeling (TUNEL) and anticaspase-3). Immunohistochemistry showed that each of the four receptors was expressed in spatially distinct zones of the developing epidermis: P2Y 1 receptors were found in the basal layer, P2X 5 receptors were predominantly in the basal and intermediate layers, and both P2Y 2 and P2X 7 receptors were in the periderm. Colocalization experiments suggested di¡erent functional roles for these receptors. P2Y 1 receptors were found in fetal keratinocytes positive for PCNA and Ki-67, suggesting a role in proliferation. P2X 5 receptors double labeled with di¡erentiated fetal keratinocytes that were positive for cytokeratin K10, suggesting a role in di¡er-entiation. P2X 7 receptors colocalized with anti-caspase-3 antibody and were also expressed in periderm cells positive for TUNEL, suggesting a role in periderm cell apoptosis. P2Y 2 receptors were found only in periderm cells and may have a role in chloride and £uid secretion into the amniotic £uid. Key words: apoptosis cell di¡eren-tiation/proliferation receptors/periderm/purinergic P2. J Invest Dermatol 121: 1145^1149, 2003 A denosine 5 0 -triphosphate (ATP) is now recognized as an important messenger molecule for cell^cell communication, with ATP binding speci¢cally to purinergic receptors (Ralevic and Burnstock, 1998) . There is increasing evidence that purinergic signaling can have long-term, trophic e¡ects in embryonic development, cell proliferation, di¡erentiation, and death (Abbracchio and Burnstock, 1998; Burnstock, 2001) .
Purinergic receptors are classi¢ed into two groups: P1 receptors are selective for adenosine and P2 receptors are selective for ATP and adenosine 5 0 -diphosphate, which act as extracellular signaling molecules (Burnstock, 1978) . P2 receptors are divided into two main families: P2X (ligand-gated ion channels) and P2Y (G-protein-coupled receptors), based on molecular structure, transduction mechanisms, and pharmacologic properties (Abbracchio and Burnstock, 1994) . Eight subtypes of P2Y receptors have been described, and seven subtypes of P2X receptors are recognized (Burnstock, 2003) .
ATP is likely to be an important local messenger in the epidermis. Both P2X 5 and P2X 7 receptors are expressed on adult rat cutaneous keratinocytes and functional roles in the regulation of proliferation, di¡erentiation, and cell death have been proposed (Gr˛schel-Stewart et al, 1999) . P2Y 2 receptors, found in the basal layer of normal adult epidermis, are claimed to be involved in keratinocyte proliferation (Dixon et al, 1999) . Studies on adult human epidermis and primary keratinocyte cultures have suggested that P2Y 1 and P2Y 2 receptors are involved in keratinocyte proliferation, that P2X 5 receptors are likely to be involved in keratinocyte di¡erentiation, and that P2X 7 receptors are likely to be part of the machinery of end stage terminal di¡erentiation/apoptosis of keratinocytes (Greig et al, 2003) .
Human fetal skin is unique in structure and function and is in a continuum of change until birth. The transition from fetal to mature epidermis of the neonate and adult involves formation of new epidermal layers, invagination and remodeling of epidermal appendages, and ¢nally loss of fetal-speci¢c cell types and onset of adult-type di¡erentiation (see Holbrook and Ho¡, 1984 , for a review). The primitive epidermis is established at 7 to 8 d when ectoderm and endoderm are de¢ned in the inner cell mass of the implanted blastocyst. At this stage the epidermis is a singlelayered ''indi¡erent ectoderm. ''A second epidermal layer forms at the end of the fourth week. The outermost of the two layers is the periderm. The periderm is the transient, protective covering of the epidermis that is sloughed into the amniotic £uid as soon as di¡erentiation of the underlying epidermal layers is complete at 20 to 24 wk. Beneath the periderm, basal keratinocytes comprise the single layer of the ''epidermis proper. ''At the end of the ninth week, the embryonic^fetal transition, basal cells divide to give rise to daughter cells that move vertically to form the ¢rst intermediate cell layer that characterizes the fetal epidermis. the adult nomenclature as the tissue assumes the adult characteristics. The ¢rst stratum corneum develops at the end of the second trimester (24 wk), consisting of only a few cell layers, which increase in thickness during the third trimester and, at birth, it is approximately equivalent to that of the adult.
This study demonstrates the distribution of P2X and P2Y receptors in human fetal epidermis.We propose that these receptors are part of the normal mechanisms controlling fetal epidermal development in relation to keratinocyte proliferation, di¡erentia-tion, and apoptosis.
MATERIALS AND METHODS
Tissues Twenty-¢ve samples of normal human fetal skin were examined from nine fetuses at 8 to 11 wk estimated gestational age, which was determined by fetal measurements after pregnancy termination. Samples were obtained from fully informed, consenting patients undergoing elective terminations of pregnancy. Ethics Committee approval was obtained to harvest human fetal samples. Tissue was frozen in isopentane precooled in liquid nitrogen. Blocks were sectioned at 10 mm on a cryostat (Reichert Jung CM1800), collected on gelatin-coated slides, and air-dried at room temperature. The slides were stored at À201C.
Antibodies
The immunogens used for production of polyclonal P2X 5 and P2X 7 antibodies were synthetic peptides corresponding to 15 receptor-type-speci¢c amino acids in the intracellular C-termini of the cloned rat and human P2X receptors, as described previously (Gr˛schel-Stewart et al, 1999; Oglesby et al, 1999) . P2X 5 and P2X 7 antibodies (provided by Roche Bioscience, Palo Alto, CA) were kept frozen at a stock concentration of 1 mg per mL. Polyclonal anti-P2Y 1 and P2Y 2 antibodies were obtained from Alomone Laboratories (Jerusalem, Israel) and corresponded to the third extracellular loop of the P2Y 1 (amino acids 242^258) and P2Y 2 receptor (amino acids 227^244). Antibodies were kept frozen at a stock concentration of 0.6 mg per mL (P2Y 1 , P2Y 2 ). Proliferating cell nuclear antigen (PCNA) is a marker for proliferation in normal adult human keratinocytes (Miyagawa et al, 1989) . Cytokeratin K10 and involucrin are markers for keratinocyte di¡erentiation (Eckert et al, 1997) . PCNA (monoclonal anti-PCNA, clone PC10, raised in mouse ascites £uid; Sigma Chemical Co., Poole, UK), cytokeratin K10 (BioGenex, San Ramon, CA), and involucrin (Sigma Chemical Co.) antibodies were raised in mouse. Ki-67 antigen is a marker for cell proliferation in normal human keratinocytes (Tucci et al, 1998) . Active caspase-3 is part of the apoptotic machinery of the cell and is expressed in terminally di¡erentiating keratinocytes (Weil et al, 1999) . Ki-67 (Dako, Denmark) and active caspase-3 (Abcam, Cambridge, UK) antibodies were both raised in rabbit.
Immunohistochemistry: double-labeling techniques. Double labeling of P2X or P2Y receptor antibodies with PCNA, cytokeratin K10, or involucrin For immunostaining of cryostat sections, the avidinb iotin technique was used according to a revised protocol (LlewellynSmith et al, 1992) . Air-dried sections were ¢xed for 2 min in 4% formaldehyde in 0.1 M phosphate bu¡er, containing 0.2% of a saturated solution of picric acid (pH 7.4). Endogenous peroxidase was blocked for 10 min with 50% methanol containing 0.4% hydrogen peroxide. Nonspeci¢c binding sites were blocked by a 20-min preincubation in 10% normal horse serum in 0.1 M phosphate bu¡er, containing 0.05% merthiolate (Sigma Chemical Co.), followed by incubation with the primary antibodies diluted to 1:100 or 1:200 in antibody diluent (10% normal horse serum in phosphate-bu¡ered saline (PBS) þ 2.5% sodium chloride at 41C overnight.
After a wash step, biotinylated donkey anti-rabbit IgG antibody, diluted 1:500 in 1% normal horse serum in PBS, was then applied for 1 h followed by streptavidin^Texas red (Amersham International plc., UK), diluted 1:200 in PBS^merthiolate for 1 h at room temperature. Sections were preincubated for 30 min with 10% normal goat serum diluted in 0.1 M phosphate bu¡er, containing 0.05% merthiolate (Sigma Chemical Co.). They were then incubated for 2 h at room temperature with one of the following antibodies: PCNA antibody (Sigma Chemical Co.) diluted 1:1000; mouse anti-human cytokeratin K10 (BioGenex) diluted 1:50; mouse monoclonal anti-involucrin (Sigma Chemical Co.) diluted 1:50. After a wash step, the directly labeled secondary antibody goat anti-mouse FITC (Nordic Immunological Laboratories, Tilburg, the Netherlands) was applied at a dilution of 1:200 for 1 h, and then sections were washed and mounted in Citi£uor (Citi£uor Ltd, Leicester, UK). P2X or P2Y receptor immunostaining appeared red and PCNA, cytokeratin K10, and involucrin stained green. Double-labeling of P2X or P2Y receptor antibodies with either Ki-67 antigen or antihuman caspase-3 Sections were ¢xed and incubated with P2X or P2Y antibodies overnight, as described above. After being washed, sections were incubated with biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratory) diluted to 1:500 in 1% normal horse serum in PBS for 1 h, followed by ExtrAvidin peroxidase conjugate (Sigma Chemical Co.) diluted to 1:1500 in PBS for 1 h, tyramide ampli¢cation for 8 min (tyramide ampli¢cation kit, NEN Life Science Products, Boston, MA) and then streptavidin^Texas red (Amersham International plc.), diluted 1:200 in PBS^merthiolate for 10 min. Sections were washed three times in PBS after each of the above steps. Sections were preincubated for 20 min in 10% normal goat serum and then incubated at room temperature for 2 h with one of the following antibodies: rabbit anti-human Ki-67 antigen (Dako) 1:50 or rabbit antihuman active caspase-3 (Abcam). Sections were then washed and incubated with the directly labeled secondary antibody Oregon-greenlabeled goat anti-rabbit IgG (Jackson ImmunoResearch Laboratory), diluted 1:100 for 45 min. Sections were then washed and mounted in Citi£uor (Citi£uor Ltd). P2X or P2Y receptor immunostaining appeared red and Ki-67 and caspase-3 stained green.
Double labeling of P2X 7 receptor antibodies with TdT-mediated dUTP nick end labeling (TUNEL) TUNEL identi¢es cells undergoing apoptosis by labeling nuclear DNA fragments that have been cleaved during apoptosis (Gavrieli et al, 1992) . TUNEL labeling was performed using a kit (Boehringer Mannheim, Germany). After overnight incubation with P2X 7 receptor antibody diluted to 1:200 as above, sections were washed in PBS and then incubated with the TUNEL reaction mixture for 1 h at 371C. As a negative control, sections were incubated with the TUNEL solution only. After additional washes in PBS, sections were incubated for 1 h with biotinylated donkey anti-rabbit antibody at a concentration of 1:500. Sections were washed in PBS and then incubated for 1 h with streptavidin^Texas red (Amersham International plc.) at a concentration of 1:200. Sections were washed in PBS and mounted in Citi£uor (Citi£uor Ltd). P2X 7 receptor immunostaining appeared red and TUNEL labeling was green.
Controls Control experiments were carried out with primary antibodies omitted from the staining procedure or the primary antibodies preabsorbed with the corresponding peptides.
Photography The results were photographed using a Zeiss Axioplan, high-de¢nition light microscope (Oberkochen, Germany) mounted with a Leica DC 200 digital camera (Heerbrugg, Switzerland).
RESULTS
P2X 5 , P2X 7 , P2Y 1 , and P2Y 2 receptor expression in human fetal epidermis P2X 5 and P2X 7 receptor immunoreactivity was observed in the epidermal keratinocytes of all human fetal skin samples (Fig 1a,b) . P2X 5 receptor immunoreactivity was found mainly in the basal layer and to a lesser extent in the intermediate cell layer (Fig 1c) . P2X 5 receptors were found in the cell membranes and sometimes in the cell cytoplasm, but not in the nucleus. The P2X 5 receptor staining on keratinocytes in the stratum basale appeared to be polarized, being concentrated on the basal aspects of cells associated with the basement membrane (Fig 1c) . In the epidermis, P2X 7 receptor immunoreactivity was associated with periderm cells only (Fig 1d) ; P2X 7 receptor immunostaining also labeled fetal blood cells. P2Y 1 receptors were found in the basal layer of the epidermis (Fig 1e) and P2Y 2 receptors were expressed only in the periderm (Fig 1f) . Double labeling of P2Y 1 and P2Y 2 receptors with markers for cellular proliferation Fetal skin was double-stained for Ki-67 and P2Y 1 receptors (Fig 1g) and PCNA and P2Y 2 receptors (Fig 1h) . The proliferation markers identi¢ed a proliferating subpopulation of basal keratinocytes. Cells positive for these two markers were also positive for P2Y 1 but not for P2Y 2 receptors, which were only found in periderm cells. Double labeling of P2X 5 receptors with markers for keratinocyte di¡erentiation Double labeling of P2X 5 receptors with cytokeratin K10 (Fig 1i) showed that P2X 5 receptors were expressed in di¡erentiating keratinocytes within the fetal epidermis. Cytokeratin K10, an early marker of keratinocyte di¡erentiation, was found in cells in the intermediate cell layer and not in basal keratinocytes. The basal layer stained only for P2X 5 receptors, and not for markers of di¡erentiation, indicating that no di¡erentiation was taking place in these cells. Involucrin, a late marker of keratinocyte di¡erentiation in adult skin, was expressed only in the periderm cells and did not colocalize with P2X 5 receptor staining (Fig 1j) . Double labeling of P2X 7 receptors with markers for apoptosis in fetal epidermis show colocalization Individual rounded periderm cells had nuclei that stained strongly positive for TUNEL (Fig 1k) . This corresponded to a transitional stage when the periderm is beginning the formation of a series of complex surface blebs. Double staining of the P2X 7 receptor and TUNEL showed that only intermittent cells were positive for TUNEL, although P2X 7 receptors were expressed in most of the cells in the periderm layer. The negative control for TUNEL showed no reaction. Double labeling of P2X 7 receptors with anticaspase-3 showed colocalization within the periderm (Fig 1l) .
Controls Both the omission of the primary antibody and the preabsorption with corresponding peptides were performed as controls. The immunoreaction was abolished after preabsorption of the P2X 5 , P2X 7 , P2Y 1 , or P2Y 2 receptor antibodies with the corresponding peptides, con¢rming the speci¢city of the immunoreaction.
DISCUSSION
This study has shown the ¢rst direct evidence for the expression of P2X 5 , P2X 7 , P2Y 1 , and P2Y 2 receptors in 8-to 11-wk-old human fetal epidermis, using immunohistochemistry. Four periods of human epidermal development have been identi¢ed (Dale et al, 1985) . The ¢rst is the embryonic period (before 9 wk estimated gestational age) and the others are within the fetal period: strati¢cation (9^14 wk), follicular keratinization (14^24 wk), and interfollicular keratinization (beginning approximately 24 wk). We have studied epidermal tissue at the end of the embryonic period and during the period of strati¢cation. It would be of interest to have studied fetal tissue from di¡erent stages of gestation but fresh-frozen tissue was not available for other time points.
Purinergic receptors bind ATP, which is found in all cells. Intracellular ATP can be released passively from dying, necrotic cells undergoing cytolysis, or it can be actively released from living cells by vesicular release or via ATP-binding cassette proteins (Bodin and Burnstock, 2001 ). In our study, we have seen that purinoceptors are distributed on cell membranes and in the cytoplasm. Internalization of purinoceptors has been observed in a variety of circumstances including synthesis of receptors in the cytoplasm and transport to the cell membrane (Loesch and Burnstock, 2001 ) and following prolonged exposure to ATP (Li et al, 2000) .
P2Y 1 receptors showed a strong immunopositive signal in the basal layer of the fetal epidermis, which is known to be where keratinocyte proliferation occurs (Bickenbach and Holbrook, 1987) . Double labeling of P2Y 1 receptors and keratinocyte proliferation markers Ki-67 and PCNA was performed. This con¢rmed the presence of P2Y 1 receptors in proliferating cells, indicating that this receptor is involved in keratinocyte proliferation. The distribution of P2Y 1 receptors was the same as in adult epidermis (Greig et al, 2003) .
P2X 5 receptors were expressed in the basal layer of human fetal epidermis and were also expressed in the intermediate cell layer, where cytokeratin K10, an early marker of keratinocyte di¡eren-tiation, was found. It is known that keratinocytes that initially occupy the intermediate layer of fetal epidermis from 9 to 20 wk gestation undergo only an incomplete type of di¡erentiation (Holbrook, 1991) that is not characteristic of the mature epidermis. Although not morphologically di¡erent, the intermediate cells at this stage have initiated biochemical di¡erentiation, characterized by the synthesis of epidermal di¡erentiation-speci¢c markers, keratins 1 and 10 (Dale et al, 1985) as seen in our study. The expression of these keratins is thought to herald the commitment of the keratinocyte to a program of epidermal keratinocyte di¡erentiation (Haake and Cooklis, 1997) . Double labeling of P2X 5 receptors with cytokeratin K10 showed that P2X 5 receptors were expressed in di¡erentiating keratinocytes within the fetal epidermis, so it seems likely that P2X 5 receptors are involved in fetal epidermal keratinocyte di¡erentiation. The basal layer stained only for P2X 5 receptors and not cytokeratin K10, indicating that basal cells were not di¡erentiated, so P2X 5 receptors may also have an additional role in basal keratinocytes. There is evidence from other tissues regarding the role of P2X 5 receptors. In fetal rat skeletal muscle, P2X 5 receptors are sequentially expressed during development (Ryten et al, 2001 ). P2X 5 receptors have been implicated in the regulation of osteoblastic di¡erentiation and proliferation (Hoebertz et al, 2000) and in triggering the di¡eren-tiation of skeletal muscle satellite cells (Ryten et al, 2002) .
Involucrin, a late marker of keratinocyte di¡erentiation in adult skin and a corni¢ed cell envelope precursor protein, was expressed only in periderm cells and did not colocalize with P2X 5 receptor staining. The lack of dual labeling might simply be due to the incomplete nature of epidermal di¡erentiation at this stage in development, because involucrin is a late marker of di¡erentiation. Involucrin has previously been found to be expressed only on periderm cells in fetal epidermis at the same stage of development (Akiyama et al, 1999) and is thought to be representative of a process of keratinization within the periderm, separate from the keratinization of the underlying ''proper'' epidermal layers that occurs later in development. In adult epidermis, we found that involucrin colocalized with P2X 5 receptors only in the upper layers of the stratum spinosum (Greig et al, 2003) .
Cells in the periderm were intensely stained for TUNEL and caspase-3. Double staining of the P2X 7 receptor and TUNEL showed that only intermittent cells were positive for TUNEL, although P2X 7 receptors were expressed in most of the cells in the periderm layer. Double labeling of P2X 7 receptors with anti-caspase-3 showed colocalization within the periderm. The P2X 7 receptor is unlike other P2X receptors because it is a bifunctional molecule that can be triggered to act as a channel permeable to small cations or on prolonged stimulation can form a cytolytic pore permeable to large hydrophilic molecules of up to 900 Da (Surprenant et al, 1996) . The opening of this pore results in the increase in intracellular cytosolic free calcium ions and the induction of cell death and there is increasing evidence that this process is dependent on the caspase signaling cascade (Ferrari et al, 1999) . Caspase-3 is expressed in adult terminally di¡erentiating keratinocytes (Weil et al, 1999) . During apoptosis, the nucleus condenses and DNA is fragmented by endonucleases, which can be detected by TUNEL. TUNEL-positive keratinocytes have been found in the upper regions of the granular layer of the adult epidermis, before corni¢cation (Polakowska et al, 1994; Tamada et al, 1994; Gandarillas et al, 1999) . Nuclei of individual periderm cells have been previously reported to stain positively for TUNEL from about 14 wk estimated gestational age (Polakowska et al, 1994) . In this study, the periderm was shown to exhibit characteristics consistent with apoptosis before its loss from the epidermis, which occurs at midgestation (20^24 wk). The periderm undergoes a series of morphologic changes that have been described ultrastructurally including: blebbing of the cell surface and pinching o¡ of cytoplasmic fragments, accumulation of cytoplasmic ¢laments, formation of a submembranous cell envelope, and a pyknotic nucleus (Holbrook and Odland, 1975) . These morphologic changes in the periderm are similar to those described for other cell types undergoing apoptosis (Kerr et al, 1972) and the time of their onset correlates with the appearance of markers of apoptosis (Polakowska et al, 1994) . Following the bleb stage, periderm cells also exhibit a number of regressive changes involving partial organelle degeneration and accumulation of ¢laments in the cytoplasm. It is thought that apoptosis is the mechanism by which periderm cells are deleted from the epidermis after serving their function (Polakowska et al, 1994) . In this study, it is likely that periderm cells at 8 to 11 wk estimated gestational age, which double label for P2X 7 receptors and markers of apoptosis, are showing a preliminary stage in the journey toward apoptosis, because they do not have the characteristic histologic appearance of apoptosis. The expression of P2X 7 receptors may be important in the regulation of apoptosis intrinsic to correct development.
Interestingly, P2Y 2 receptors were also found only in periderm cells. In adult skin, P2Y 2 receptors were found in the basal layer of the epidermis, where proliferation markers Ki-67 and PCNA were also found (Greig et al, 2003) . The P2Y 2 receptor agonist, uridine 5 0 -triphosphate (UTP), caused a signi¢cant increase in human keratinocyte cell number in vitro (Greig et al, 2003) . Previous work has localized P2Y 2 receptor mRNA in adult human epidermal basal cells via in situ hybridization (Dixon et al, 1999) . UTP, the potent P2Y 2 receptor agonist, has also been shown to cause proliferation in keratinocytes (Dixon et al, 1999; Greig et al, 2003) . Nevertheless, in fetal epidermis, P2Y 2-receptor-positive periderm cells were not positive for proliferation markers PCNA and Ki-67. Therefore, P2Y 2 receptors may have an alternative role in periderm cells. For example, P2Y 2 receptors on periderm cells could be involved in chloride and £uid secretion into the amniotic £uid. P2Y 2 receptors are involved in ion and £uid secretion in lung and conjunctival epithelial cells (Yerxa, 2001) . Studies have suggested that nonkeratinized fetal epidermis may have an osmoregulatory function and also that the fetal epidermis contributes to the formation of amniotic £uid in the ¢rst trimester and becomes the primary source in the second trimester (Holbrook, 1991) . Periderm cells have microvilli and surface blebs that increase the surface area of the plasma membrane exposed to the amniotic £uid, there are large numbers of membrane-bound vesicles adjacent to the plasma membrane, and tight junctions join adjacent periderm cells. This suggests that the periderm cell layer may have potential for £uid and ion transport (Holbrook, 1991) .
In summary, P2 purinergic receptors are likely to be involved in fetal keratinocyte proliferation via P2Y 1 receptors found on basal cells and fetal keratinocyte di¡erentiation via activation of P2X 5 receptors. P2X 7 receptors are likely to be involved in apoptosis of periderm cells, but the role of P2Y 2 receptors in periderm cells is currently unknown; it is suggested that they may play a role in chloride and £uid secretion into the amniotic £uid. 
